Piet Ost
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
Piet Ost
May 8, 2024, 02:11 |
Blog
Piet Ost: RADIOSA trial at ESTRO24
Piet Ost, Assistant Professor of Radiation Oncology at Ghent University, shared on X/Twitter: "RADIOSA trial: oligorecurrent…
Apr 30, 2024, 11:54 |
Societies
15 Posts Not To Miss from APCCC24!
The Advanced Prostate Cancer Consensus Conference 2024 (APCCC24) was held from April 25th to April…
Apr 27, 2024, 10:59 |
Blog
Yüksel Ürün: Debate time at Advanced Prostate Cancer Consensus Conference - Local control is NOT the problem
Yüksel Ürün, Doctorate Professor at the Faculty of Medicine, Ankara University, Turkey, shared on X/Twitter:…
Apr 27, 2024, 10:26 |
Blog
Piet Ost: Strong message from David Matheson on what the patient wants from a QoL tool
Piet Ost, Assistant Professor of Radiation Oncology at Ghent University, shared on X/Twitter: "Strong message from…
Dec 2, 2023, 17:44 |
Insight
Marco Donia: Patients undergoing immunotherapy can safely receive SBRT upon indication
Marco Donia, Clinical Research Associate Professor at University of Copenhagen, shared on LinkedIn: "Adding Stereotactic Body…
All:
5
Posts:
1 - 10
OncoInfluencers: Dialogue with Rob Pieters, hosted by Shushan Hovsepyan
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Facebook
RSS Feed
Twitter
Linkedin
Youtube